How will the FDA recommendation for use of ELISA testing methods affect the testing methods used by GFCO?
GFCO scientific and legal team will review this. At this time, GFCO is using both Skerritt and ELISA testing methods. GFCO is aware of the on-going debate in the scientific community about the sensitivity and specificity of various testing methods. Research to be published shortly suggests that both ELISA and Skerritt may have weaknesses that can be complimented by using both methods. We feel that by using both methods, we are able to more accurately assure GF status.
